Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq)) and Tivicay
Determining the interaction of Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq)) and Tivicay and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Hemofil-M, Koate-DVI, Monoclate-P, Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Jivi, Obizur
Synonyms: Antihemophilic factor (human), Antihemophilic Factor (Human)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Tivicay (Dolutegravir 10 mg)
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Tivicay (Dolutegravir 25 mg and 50 mg)
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Tivorbex
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Tizanidine
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Tizanidine Capsules
- Nuwiq (Antihemophilic Factor (Recombinant) (Nuwiq))-Tizanidine Hydrochloride
- Tivicay-Nuwiq recombinant
- Tivicay-NuZole
- Tivicay-Nuzyra
- Tivicay-Nuzyra (Omadacycline Injection)
- Tivicay-Nuzyra (Omadacycline Tablets)
- Tivicay-Nuzyra Intravenous